SEC Info - Adaptive Biotechnologies Corp. - ‘S-8’ on 2/14/23

SEC Info℠

Home

Help

Please Sign In

Adaptive Biotechnologies Corp. – ‘S-8’ on 2/14/23 – ‘EX-FILING FEES’

On: Tuesday, 2/14/23, at 4:48pm ET · Effective: 2/14/23 · Accession #: 950170-23-2798 · File #: 333-269767

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/14/23  Adaptive Biotechnologies Corp.    S-8         2/14/23    4:232K                                   Donnelley … Solutions/FA

Registration Statement – Securities for an Employee Benefit Plan — Form S-8 — SA’33

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-8         Registration Statement - Securities for an          HTML    169K 
                Employee Benefit Plan                                            
 2: EX-5        Ex-5.1                                              HTML     16K 
 3: EX-23       Ex-23.2                                             HTML      6K 
 4: EX-FILING FEES  Filing Fees                                     HTML     42K

‘EX-FILING FEES’ — Filing Fees

This is an HTML Document rendered as filed. [ Alternative Formats ]

EX-FILING FEES

Calculation of Filing Fee Table

Form S-8

(Form Type)

Adaptive Biotechnologies Corporation

(Exact Name of Registrant as Specified in its Charter)

Table 1 – Newly Registered Securities


Security Type	Security Class Title	Fee Calculation Rule	Amount Registered (1)	Proposed maximum offering price per unit	Maximum aggregate offering price	Fee Rate	Amount of Registration Fee
Equity	Common stock, $0.0001 par value per share, reserved for issuance pursuant to the 2019 Equity Incentive Plan	Rule 457(c) and Rule 457(h)	20,299,501 (2)	$8.67 (4)	$175,996,674	$110.20 per $1,000,000	$19,394.83
Equity	Common stock, $0.0001 par value per share, reserved for issuance pursuant to the 2019 Employee Stock Purchase Plan	Rule 457(c) and Rule 457(h)	2,683,431 (3)	$7.37 (5)	$19,776,886	$110.20 per $1,000,000	$2,179.41
Total Offering Amounts			22,982,932		$195,773,560		$21,574.24
Total Fee Offsets							0
Net Fee Due							$21,574.24


(1)	Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any common stock which become issuable under the above-named plans by reason of any stock dividend, stock split, recapitalization or any other similar transaction effected without the receipt of consideration which results in an increase in the number of the Registrant’s outstanding shares of common stock.
(2)	Reflects automatic annual increases on each of January 1, 2020, January 1, 2021, and January 1, 2023 to the number of shares of the Registrant’s common stock reserved for issuance under the Adaptive Biotechnologies Corporation 2019 Equity Incentive Plan (the “2019 EIP”), which annual increases are provided for in the 2019 EIP.
(3)	Reflects automatic annual increases on January 1, 2020 and January 1, 2023, to the number of shares of the Registrant’s common stock reserved for issuance under the Adaptive Biotechnologies Corporation 2019 Employee Stock Purchase Plan (the “ESPP”), which annual increase is provided for in the ESPP.


(4)	Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) and (h) under the Securities Act on the basis of $8.67 per share, which represents the average of the high and low prices of the Registrant’s common stock as reported on the Nasdaq Global Select Market on February 13, 2023.
(5)	Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) and (h) under the Securities Act, and based on 85% of $8.67 per share, which represents the average of the high and low prices of the Registrant’s common stock as reported on the Nasdaq Global Select Market on February 13, 2023.

Dates Referenced Herein and Documents Incorporated by Reference

This ‘S-8’ Filing	Date	Other Filings

Filed on / Effective on:	2/14/23	10-K, 8-K
	2/13/23	SC 13G
	1/1/23
	1/1/21
	1/1/20
		List all Filings

7 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/14/23  Adaptive Biotechnologies Corp.    10-K       12/31/22  102:31M                                    Donnelley … Solutions/FA
 5/04/22  Adaptive Biotechnologies Corp.    10-Q        3/31/22   76:8.2M                                   ActiveDisclosure/FA
 2/24/21  Adaptive Biotechnologies Corp.    10-K       12/31/20   98:18M                                    ActiveDisclosure/FA
 8/13/19  Adaptive Biotechnologies Corp.    10-Q        6/30/19   78:10M                                    ActiveDisclosure/FA
 7/01/19  Adaptive Biotechnologies Corp.    8-K:5,8,9   6/26/19    5:254K                                   Donnelley … Solutions/FA
 6/26/19  Adaptive Biotechnologies Corp.    8-A12B                 1:14K                                    Donnelley … Solutions/FA
 6/17/19  Adaptive Biotechnologies Corp.    S-1/A                 10:5.4M                                   Donnelley … Solutions/FA

↑Top

Filing Submission 0000950170-23-002798 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)